| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 48.14M | — |
| Operating expense | — | — |
| Net income | -12.16M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, CTKB returned +15.9% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -4.8% |
| 1 year | +15.9% |
| 5 years | -78.9% |
| All-time high | $22.81 (Oct 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in CTKB would be worth today ›No. Cytek Biosciences, Inc. has not paid a dividend in the past 12 months.
Cytek Biosciences, Inc. stock trades on NASDAQ under the ticker symbol CTKB.
Cytek Biosciences, Inc. is part of the Healthcare sector.
Cytek Biosciences, Inc. has a market cap of 625.22M USD, based on the latest quote.
Cytek Biosciences, Inc. is expected to report earnings around Nov 4, 2026. That date is an estimate and has not been confirmed by the company.
